89 related articles for article (PubMed ID: 18646206)
1. Differential MRI patterns of brain atrophy in double or single transgenic mice for APP and/or SOD.
Borg J; Chereul E
J Neurosci Res; 2008 Nov; 86(15):3275-84. PubMed ID: 18646206
[TBL] [Abstract][Full Text] [Related]
2. Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein [correction].
Harris-Cerruti C; Kamsler A; Kaplan B; Lamb B; Segal M; Groner Y
Eur J Neurosci; 2004 Mar; 19(5):1174-90. PubMed ID: 15016076
[TBL] [Abstract][Full Text] [Related]
3. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.
Iadecola C; Zhang F; Niwa K; Eckman C; Turner SK; Fischer E; Younkin S; Borchelt DR; Hsiao KK; Carlson GA
Nat Neurosci; 1999 Feb; 2(2):157-61. PubMed ID: 10195200
[TBL] [Abstract][Full Text] [Related]
4. Striatum and entorhinal cortex atrophy in AD mouse models: MRI comprehensive analysis.
Micotti E; Paladini A; Balducci C; Tolomeo D; Frasca A; Marizzoni M; Filibian M; Caroli A; Valbusa G; Dix S; O'Neill M; Ozmen L; Czech C; Richardson JC; Frisoni GB; Forloni G
Neurobiol Aging; 2015 Feb; 36(2):776-88. PubMed ID: 25433456
[TBL] [Abstract][Full Text] [Related]
5. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice.
Delatour B; Guégan M; Volk A; Dhenain M
Neurobiol Aging; 2006 Jun; 27(6):835-47. PubMed ID: 16023262
[TBL] [Abstract][Full Text] [Related]
6. APP/SOD1 overexpressing mice present reduced neuropathic pain sensitivity.
Kotulska K; Larysz-Brysz M; LePecheur M; Marcol W; Olakowska E; Lewin-Kowalik J; London J
Brain Res Bull; 2011 Jul; 85(6):321-8. PubMed ID: 21605634
[TBL] [Abstract][Full Text] [Related]
7. Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.
Carlson GA; Borchelt DR; Dake A; Turner S; Danielson V; Coffin JD; Eckman C; Meiners J; Nilsen SP; Younkin SG; Hsiao KK
Hum Mol Genet; 1997 Oct; 6(11):1951-9. PubMed ID: 9302276
[TBL] [Abstract][Full Text] [Related]
8. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
9. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.
Helpern JA; Lee SP; Falangola MF; Dyakin VV; Bogart A; Ardekani B; Duff K; Branch C; Wisniewski T; de Leon MJ; Wolf O; O'Shea J; Nixon RA
Magn Reson Med; 2004 Apr; 51(4):794-8. PubMed ID: 15065253
[TBL] [Abstract][Full Text] [Related]
10. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.
Schuessel K; Schäfer S; Bayer TA; Czech C; Pradier L; Müller-Spahn F; Müller WE; Eckert A
Neurobiol Dis; 2005 Feb; 18(1):89-99. PubMed ID: 15649699
[TBL] [Abstract][Full Text] [Related]
11. Comparison of manual and semi-automated segmentation methods to evaluate hippocampus volume in APP and PS1 transgenic mice obtained via in vivo magnetic resonance imaging.
Hayes K; Buist R; Vincent TJ; Thiessen JD; Zhang Y; Zhang H; Wang J; Summers AR; Kong J; Li XM; Martin M
J Neurosci Methods; 2014 Jan; 221():103-11. PubMed ID: 24091139
[TBL] [Abstract][Full Text] [Related]
12. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
14. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
Kumar-Singh S; Dewachter I; Moechars D; Lübke U; De Jonghe C; Ceuterick C; Checler F; Naidu A; Cordell B; Cras P; Van Broeckhoven C; Van Leuven F
Neurobiol Dis; 2000 Feb; 7(1):9-22. PubMed ID: 10671319
[TBL] [Abstract][Full Text] [Related]
15. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
[TBL] [Abstract][Full Text] [Related]
16. Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.
Bigot C; Vanhoutte G; Verhoye M; Van der Linden A
Neuroimage; 2014 Feb; 87():111-9. PubMed ID: 24188815
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance T2 relaxation time at 7 Tesla associated with amyloid β pathology and age in a double-transgenic mouse model of Alzheimer's disease.
Li L; Wang XY; Gao FB; Wang L; Xia R; Li ZX; Xing W; Tang BS; Zeng Y; Zhou GF; Zhou HY; Liao WH
Neurosci Lett; 2016 Jan; 610():92-7. PubMed ID: 26520465
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein.
Li G; Zou L; Jack CR; Yang Y; Yang ES
Neurobiol Aging; 2007 Jun; 28(6):877-82. PubMed ID: 16806588
[TBL] [Abstract][Full Text] [Related]
19. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
